CHINA SKY ONE MEDICL (CSKI)

Milberg LLP announces that a class action lawsuit was filed on behalf of all purchasers of China Sky One Medical, Inc.

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased China Sky One Medical, Inc.

Rigrodsky & Long, P.A.

The Rosen Law Firm, P.A.

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of China Sky One Medical, Inc.

China Sky One Medical (Nasdaq:CSKI) has been downgraded by TheStreet Ratings from from a hold to sell.

During the past week, global indices recovered losses, partially spurred by a few positive economic developments.

Shares of China Sky One Medical (Nasdaq:CSKI) have taken a tremendous swing upward. The stock is trading at $3.23 as of 3:41 p.m. ET, 23.3% above Thursday's closing price of $2.62. Volume is at 528,537, 4.3 times the daily average of 122,300.

Shares of China Sky One Medical (Nasdaq:CSKI) have taken a tremendous swing upward. The stock is trading at $2.57 as of 2:25 p.m. ET, 20.7% above Wednesday's closing price of $2.13. Volume is at 151,799, 1.2 times the daily average of 123,500.

Hear are some of the major headlines that have moved China small-cap stocks so far in 2011.

The regulator's investor bulletins usually are released too late. Here are some suggestions.

Chinese reverse-merger company Duoyuan Printing reveals that securities regulators have been investigating the company for fraud.

A day after China MediaExpress says its CFO and audit firm have resigned, a handful of small-cap Chinese stocks sold off sharply.

Shares of China Sky One Medical (Nasdaq:CSKI) have taken a tremendous swing upward. The stock is trading at $5.68 as of 11:51 a.m. ET, 21.6% above Tuesday's closing price of $4.67. Volume is at 561,814, 2.8 times the daily average of 199,600.

Buffeted by allegations of fraud and an ongoing SEC probe, China Sky One issues a letter to its 'loyal shareholders' and invites one and all to visit its operations in Harbin City.

As bears and bulls battle, the fates of Chinese small-caps often hang in the balance.

Texas investor John Bird details his ordeal with China Sky One Medical's conflicting numbers.

Some U.S.- listed China stocks leave themselves vulnerable to speculation of fraud even when none exists.

An investigation follows more than $34 billion in losses by investors in questionable Chinese companies traded in the U.S. TheStreet examines the issue.

China Jo-Jo Drugstores' growth is poised to explode, although the company remains speculative.

Investors who think Chinese stocks deserve the reputation of having less credible corporate management and poorer internal controls than U.S. companies are going to foolishly miss out on great growth opportunities, a new poll finds.

Visa and Mastercard were among companies to hit fresh 52-week lows Monday morning.

Several stocks trading below $10, including China Sky One Medical, were poised to move on above-average volume Tuesday.

Shares of China Sky One Medical fell sharply in extended trades after the company cut its financial outlook, while Brocade shares edged higher.

Despite strong earnings growth, China Sky One Medical and Skystar Bio-Pharmaceuticals have experienced significant declines and are now presenting attractive buying opportunities.

Two undervalued pharmaceutical stocks from China could outperform U.S. drug giants Pfizer and Merck.

Trading volume in the market has remained at a troublingly low level.

Here are three exceptional Chinese pharmaceutical companies that are very undervalued compared to their U.S. counterparts.